News

Janagliflozin (Ganagliflozin Proline Tablets): Mechanism of Action and Clinical Insights

Janagliflozin, also known as Ganagliflozin Proline Tablets, marketed under the brand name HuiYouJing, is an…

On October 11, 2024, Junshi Biosciences announced that its self-developed recombinant humanized anti-PCSK9 monoclonal antibody…

In the fight against severe and chronic auto-inflammatory diseases, Rilonacept Injection has emerged as a…

February 2025 – In a groundbreaking advancement in the treatment of platinum-resistant ovarian cancer, the…

February 2025 — In a significant advancement in the treatment of certain aggressive cancers, Sacituzumab…

In 2024, several new lung cancer treatments, including Unecritinib Fumarate Capsules, Tarlatamab, Zenocutuzumab, Lazertinib and…

$Loncastuximab Tesirine-Lpyl: A New Hope For Patients With Relapsed Or Refractory Large B-Cell Lymphoma$

February 2025 — In a significant breakthrough for cancer treatment, Loncastuximab Tesirine-lpyl (brand name Zynlonta)…

In the rapidly advancing world of cancer treatment, Lunsumio(Mosunetuzumab) has emerged as a promising new…

In the ever-evolving landscape of oncology, a promising new drug, Zolbetuximab-Clzb for Injection, has made…

In recent years, Vindesine Sulfate For Injection, as a chemotherapeutic drug, has demonstrated remarkable efficacy…